192 related articles for article (PubMed ID: 2420219)
1. An immunohistochemical study of thymic epithelial tumors. I. Epithelial component.
Kodama T; Watanabe S; Sato Y; Shimosato Y; Miyazawa N
Am J Surg Pathol; 1986 Jan; 10(1):26-33. PubMed ID: 2420219
[TBL] [Abstract][Full Text] [Related]
2. The MIC2 antibody 013. Practical application for the study of thymic epithelial tumors.
Chan JK; Tsang WY; Seneviratne S; Pau MY
Am J Surg Pathol; 1995 Oct; 19(10):1115-23. PubMed ID: 7573670
[TBL] [Abstract][Full Text] [Related]
3. Thymic carcinoma arising in thymoma is associated with alterations in immunohistochemical profile.
Kuo TT; Chan JK
Am J Surg Pathol; 1998 Dec; 22(12):1474-81. PubMed ID: 9850173
[TBL] [Abstract][Full Text] [Related]
4. Cytokeratins in normal thymus and thymic epithelial tumors.
Fukai I; Masaoka A; Hashimoto T; Yamakawa Y; Mizuno T; Tanamura O
Cancer; 1993 Jan; 71(1):99-105. PubMed ID: 7677978
[TBL] [Abstract][Full Text] [Related]
5. Relationship between structure and T-lymphocyte maturation in human thymomas. Enzyme histochemical and immunohistological studies.
Palestro G; Valente G; Novero D; Stramignoni D; Geuna M; Rosai J
Virchows Arch B Cell Pathol Incl Mol Pathol; 1987; 52(5):389-402. PubMed ID: 2883762
[TBL] [Abstract][Full Text] [Related]
6. Immunoreactivity of a new CD5 antibody with normal epithelium and malignant tumors including thymic carcinoma.
Tateyama H; Eimoto T; Tada T; Hattori H; Murase T; Takino H
Am J Clin Pathol; 1999 Feb; 111(2):235-40. PubMed ID: 9930146
[TBL] [Abstract][Full Text] [Related]
7. Thymic carcinomas, but not thymomas and carcinomas of other sites, show CD5 immunoreactivity.
Dorfman DM; Shahsafaei A; Chan JK
Am J Surg Pathol; 1997 Aug; 21(8):936-40. PubMed ID: 9255257
[TBL] [Abstract][Full Text] [Related]
8. Desmoglein 3 and p40 immunoreactivity in neoplastic and nonneoplastic thymus: a potential adjunct to help resolve selected diagnostic and staging problems.
Walts AE; Hiroshima K; Marchevsky AM
Ann Diagn Pathol; 2015 Aug; 19(4):216-20. PubMed ID: 25979154
[TBL] [Abstract][Full Text] [Related]
9. Demonstration of phenotypic abnormalities of thymic epithelium in thymoma including two cases with abundant Langerhans cells.
Kraus VB; Harden EA; Wittels B; Moore JO; Haynes BF
Am J Pathol; 1988 Sep; 132(3):552-62. PubMed ID: 3261946
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical studies in human thymomas. Localization of thymosin and various cell marker.
Hirokawa K; Utsuyama M; Moriizumi E; Hashimoto T; Masaoka A; Goldstein AL
Virchows Arch B Cell Pathol Incl Mol Pathol; 1988; 55(6):371-80. PubMed ID: 2904193
[TBL] [Abstract][Full Text] [Related]
11. An immunohistologic study of the epithelial and lymphoid components of six thymomas.
van der Kwast TH; van Vliet E; Cristen E; van Ewijk W; van der Heul RO
Hum Pathol; 1985 Oct; 16(10):1001-8. PubMed ID: 2412943
[TBL] [Abstract][Full Text] [Related]
12. Thymic carcinoma. A clinicopathologic study of 13 cases.
Truong LD; Mody DR; Cagle PT; Jackson-York GL; Schwartz MR; Wheeler TM
Am J Surg Pathol; 1990 Feb; 14(2):151-66. PubMed ID: 1689123
[TBL] [Abstract][Full Text] [Related]
13. The distribution of epithelial membrane antigen in thymic epithelial neoplasms.
Fukai I; Masaoka A; Hashimoto T; Yamakawa Y; Mizuno T; Tanamura O
Cancer; 1992 Oct; 70(8):2077-81. PubMed ID: 1394038
[TBL] [Abstract][Full Text] [Related]
14. Immunohistological evidences of cortical and medullary differentiation in thymoma.
Müller-Hermelink HK; Marino M; Palestro G; Schumacher U; Kirchner T
Virchows Arch A Pathol Anat Histopathol; 1985; 408(2-3):143-61. PubMed ID: 3936257
[TBL] [Abstract][Full Text] [Related]
15. Intrathyroidal epithelial thymoma (ITET)/carcinoma showing thymus-like differentiation (CASTLE) exhibits CD5 immunoreactivity: new evidence for thymic differentiation.
Dorfman DM; Shahsafaei A; Miyauchi A
Histopathology; 1998 Feb; 32(2):104-9. PubMed ID: 9543665
[TBL] [Abstract][Full Text] [Related]
16. Neuroendocrine differentiation in thymic epithelial tumors with special reference to thymic carcinoma and atypical thymoma.
Hishima T; Fukayama M; Hayashi Y; Fujii T; Arai K; Shiozawa Y; Funata N; Koike M
Hum Pathol; 1998 Apr; 29(4):330-8. PubMed ID: 9563781
[TBL] [Abstract][Full Text] [Related]
17. The clinicopathological significance of thymic epithelial markers expression in thymoma and thymic carcinoma.
Li H; Ren B; Yu S; Gao H; Sun PL
BMC Cancer; 2023 Feb; 23(1):161. PubMed ID: 36797681
[TBL] [Abstract][Full Text] [Related]
18. Thymoma: an immunohistochemical study.
Chan WC; Zaatari GS; Tabei S; Bibb M; Brynes RK
Am J Clin Pathol; 1984 Aug; 82(2):160-6. PubMed ID: 6380266
[TBL] [Abstract][Full Text] [Related]
19. PE-35-related antigen expression and CD1a-positive lymphocytes in thymoma subtypes based on Müller-Hermelink classification. An immunohistochemical study using catalyzed signal amplification.
Hattori H; Tateyama H; Tada T; Saito Y; Yamakawa Y; Eimoto T
Virchows Arch; 2000 Jan; 436(1):20-7. PubMed ID: 10664158
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric analysis of lymphoid cells in thymic epithelial neoplasms.
Nakajima J; Takamoto S; Oka T; Tanaka M; Takeuchi E; Murakawa T
Eur J Cardiothorac Surg; 2000 Sep; 18(3):287-92. PubMed ID: 10973537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
